Dr. Nguyen shares how breast cancer patients in rural areas can overcome travel barriers and confidently discuss clinical ...

Dr. Thomas Flaig highlights the importance of multidisciplinary care and clinical trials in guiding personalized bladder cancer treatment decisions. At the 2026 NCCN Annual Conference, Dr. Thomas ...

Cancer care innovations are outpacing delivery and payment systems, necessitating sustainable access models and addressing disparities in care. CAR T-cell therapy and bispecific antibodies show ...

OneOncology's acquisition of Navigating Cancer aims to enhance technology adoption in community oncology practices. Navigating Cancer will remain a standalone entity, with increased investment to ...

Medical and scientific advancements have given new hopes for the treatment and prevention of cancer. On May 6, join Washington Post Live for a series of conversations about the progress made and ways ...

Implementing large language model-based artificial intelligence (AI) technology in proposing effective treatment plans in patients with cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...

Rapid advancements in science are transforming our understanding and treatment of cancer, bringing new hope to patients. This accelerating pace of innovation, while groundbreaking, also presents ...

A cancer diagnosis goes beyond a medical condition. It’s a life-altering event that can impact every facet of a person’s well-being. Besides the physical toll of treatment, the emotional, mental, and ...

In "Beyond Diagnosis: Breast Cancer," Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels continue their conversations on communicating effectively and empathetically with patients ...

Awareness months, like this month’s Colorectal Cancer Awareness Month, play a crucial role in spreading knowledge about risk factors, symptoms, screenings and more because early detection saves lives.

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...